These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Influence of fluoroquinolone consumption in inpatients and outpatients on ciprofloxacin-resistant Escherichia coli in a university hospital. Gallini A; Degris E; Desplas M; Bourrel R; Archambaud M; Montastruc JL; Lapeyre-Mestre M; Sommet A J Antimicrob Chemother; 2010 Dec; 65(12):2650-7. PubMed ID: 20876240 [TBL] [Abstract][Full Text] [Related]
27. Emergence of fluoroquinolone-resistant Escherichia coli as cause of postprostate biopsy infection: implications for prophylaxis and treatment. Zaytoun OM; Vargo EH; Rajan R; Berglund R; Gordon S; Jones JS Urology; 2011 May; 77(5):1035-41. PubMed ID: 21420152 [TBL] [Abstract][Full Text] [Related]
30. Fluoroquinolone resistance trends and animal drug use: a retrospective analysis. Radostits OM Int J Infect Dis; 2004 May; 8(3):187-9; author reply 190-2. PubMed ID: 15109595 [No Abstract] [Full Text] [Related]
31. The magnitude of the association between fluoroquinolone use and quinolone-resistant Escherichia coli and Klebsiella pneumoniae may be lower than previously reported. Bolon MK; Wright SB; Gold HS; Carmeli Y Antimicrob Agents Chemother; 2004 Jun; 48(6):1934-40. PubMed ID: 15155181 [TBL] [Abstract][Full Text] [Related]
32. Antimicrobial resistance in internal medicine wards. Menichetti F; Tagliaferri E Intern Emerg Med; 2012 Oct; 7 Suppl 3():S271-81. PubMed ID: 23073868 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of several fluoroquinolones and beta-lactams in terms of their capability to restrict the selection of fluoroquinolone-resistant Salmonella: in vitro models. Cebríán L; Rodríguez JC; Escribiano I; Royo SG APMIS; 2007 Dec; 115(12):1376-82. PubMed ID: 18184408 [TBL] [Abstract][Full Text] [Related]
34. Fluoroquinolone resistance: overuse of fluoroquinolones in human and veterinary medicine can breed resistance. Piddock LJ BMJ; 1998 Oct; 317(7165):1029-30. PubMed ID: 9774285 [No Abstract] [Full Text] [Related]
35. Impact of restricting fluoroquinolone prescription on bacterial resistance in an intensive care unit. Aubert G; Carricajo A; Vautrin AC; Guyomarc'h S; Fonsale N; Page D; Brunel P; Rusch P; Zéni F J Hosp Infect; 2005 Feb; 59(2):83-9. PubMed ID: 15620440 [TBL] [Abstract][Full Text] [Related]
36. Clinical implications of pharmacokinetics and pharmacodynamics of fluoroquinolones. Wispelwey B Clin Infect Dis; 2005 Jul; 41 Suppl 2():S127-35. PubMed ID: 15942879 [TBL] [Abstract][Full Text] [Related]
37. Emergence of fluoroquinolone resistance in Escherichia coli isolates at the department of clinical hematology. Zemkova M; Kotlarova J; Merka V; Cermak P; Vlcek J; Jebavy L New Microbiol; 2007 Oct; 30(4):423-30. PubMed ID: 18080678 [TBL] [Abstract][Full Text] [Related]